gms | German Medical Science

72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

06.06. - 09.06.2021

Article

Send article

Analgesic pharmacotherapy costs, regimen, and impact on postoperative pain-related functioning

Kosten, Behandlungsschema und Auswirkungen der analgetischen Pharmakotherapie auf die postoperative Schmerzfunktion

Meeting Abstract

Search Medline for

  • presenting/speaker Dorota Kopciuch - Poznań University of Medical Sciences, Pharmacoeconomics and Social Pharmacy, Posen, Polen
  • Anna-Maria Barciszewska - Poznań University of Medical Sciences, Department of Neurosurgery and Neurotraumatology, Posen, Polen; Heliodor Swiecicki Clinical Hospital in Poznan, Department of Neurosurgery and Neurotraumatology, Posen, Polen
  • Anna Paczkowska - Poznań University of Medical Sciences, Pharmacoeconomics and Social Pharmacy, Posen, Polen
  • Tomasz Zaprutko - Poznań University of Medical Sciences, Pharmacoeconomics and Social Pharmacy, Posen, Polen
  • Piotr Ratajczak - Poznań University of Medical Sciences, Pharmacoeconomics and Social Pharmacy, Posen, Polen
  • Krzysztof Kus - Poznań University of Medical Sciences, Pharmacoeconomics and Social Pharmacy, Posen, Polen

Deutsche Gesellschaft für Neurochirurgie. 72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie. sine loco [digital], 06.-09.06.2021. Düsseldorf: German Medical Science GMS Publishing House; 2021. DocJM-PSN-05

doi: 10.3205/21dgnc252, urn:nbn:de:0183-21dgnc2522

Published: June 4, 2021

© 2021 Kopciuch et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.

Outline

Text

Objective: To analyze the impact of analgesic pharmacotherapy used after spine surgery on subjective quality of life and pain relief of patients with lumbar degenerative vertebral disc disease.

Methods: Fifty patients with LDVDD in L5/S1 and L4/L5 spine section who were qualified for spine surgery were recruited into this study.

The outcomes of postoperative pain and functional outcomes were recorded using standarised questionnaires.

Results: The greatest improvement in functioning between baseline and follow-up measurements was observed in the group of patients treated with non-opioids. Total average pharmacotherapy cost amounted to EUR 453.42 (±49.09).

Conclusion: This study supports the notion that pain pharmacotherapies could potentially be differentiated in terms of overall impact on quality of life, and that pain-related distress might be the most relevant driver of quality of life in this setting.